Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells

Neuropathology and Applied Neurobiology

Volumn 25, Issue 2, 1999, Pages 104-112

  Machein, M R ^d   Kullmer, J ^d   Ronicke V ^b   Machein, U ^a   Krieg, M ^d   Damert, A ^b   Breier, G ^b   Risau, W ^b   Plate, K H ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c Neurozentrum   (Germany)

^d NONE

Author keywords

Brain oedema; Brain tumour; Dexamethasone; Gliomas; VEGF

Indexed keywords

DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; PROGESTERONE; PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN TUMOR; CELL LINE; DOWN REGULATION; ENDOTHELIUM CELL; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL ANALYSIS; SUBCUTANEOUS TISSUE; TUMOR GROWTH; UMBILICAL VEIN;

ANIMALS; CELL HYPOXIA; CELL LINE; DEXAMETHASONE; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ESTRADIOL; GLIOMA; GLUCOCORTICOIDS; HUMANS; LYMPHOKINES; PROGESTERONE; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032924145     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00166.x     Document Type: Article

References (39)

1. 1 Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-7
2. 2 Berkman RA, Merrill MJ, Reinhold WC et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91: 153-9
3. 3 Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Dev 1992; 114: 521-32
4. 4 Chomczinsky P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9
5. 5 Clauss M, Weich H, Breier G et al . The vascular endothelial growth factor receptor flt-1 mediates biological activities. J Biol Chem 1996; 271: 17629-34
6. 6 Criscuolo GR. The genesis of peritumoural vasogenic brain oedemaand tumour cysts: a hypothetical role for tumour-derived vascular permeability factor. Yale J Biol Med 1996; 66: 277-314
7. 7 Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus rapid stimulation by estrogen correlates with estrogen-induced increases in uterine permeability and growth. Endocrinol 1993; 133: 829-37
8. 8 Damert A, Machein M, Breier G et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997; 57: 3860-4
9. 9 Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch JC. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5,2-,2-Nitro-1H-imidazol-1-YL-N-2,2,3,3,3-Pentafluoropropyl Acetamide. British J Cancer 1995; 72: 875-82
10. 10 Finkenzeller G, Technau A, Marme D. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Comm 1995; 208: 432-9
11. 11 Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible fador-1. Mol Cell Biol 1996; 16: 4604-13
12. 12 Galicich JH, French LA, Melby JC. Use of dexamethasone in treatment of cerebral oedema associated with brain tumours. J Lancet (Minneapolis) 1961; 81: 46-53
13. 13 Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5
14. 14 Heiss JD, Papavassiliou E, Merill MJ et al. Mechanism of dexamethasone suppression of brain tumour associated vascular permeability in rats. J Clin Invest 1996; 98: 1400-8
15. 15 Hirano A, Matsui T. Vascular structures in brain tumours. Human Pathol 1975; 6: 611-21
16. 16 Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995; 270: 19761-6
17. 17 Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis Endorinol 1993; 133: 848-59
18. 18 Jonat C, Rahmsdorf HJ, Park K-K et al. Antitumour-promotion and untiinflammation: down-modulation of AP-1, Fos/Jun activity by glucocorticoid hormone. Cell 1990; 62: 1189-204
19. 19 Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells Role in corpus luteum development. Am J Pathol 1995; 146: 157-65
20. 20 Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-4
21. 21 Kremer C, Breier G, Risau W, Plate KH. Upregulation of flk-1/VEGF receptor-2 by its ligand in a cerebral slice culture system. Cancer Res 1997; 57: 3852-9
22. 22 Kristjansen PEG, Boucher Y, Jain RK. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma model. Cancer Res 1993; 53: 4764-6
23. 23 Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996; 271: 2746-53
24. 24 Long M. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumours. J Neurosurg 1970; 32: 127-44
25. 25 Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res 1993; 53: 5822-7
26. 26 Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-7
27. 27 Reichman HR, Farrell CL, del Maestro RF. Effects of steroids and non-steroid anti-inflamatory agents on vascular permeability in a rat glioma model. J Neurosurg 1986; 65: 235-7
28. 28 Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108: 2369-79
29. 29 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor Laboratory, 1989 :1666-7
30. 30 Senger DR, Van de Water L, Brown LF et al. Vascular permeability factor (VPF, VEGF) in tumour biology. Cancer Metastasis Rev 1993; 12: 303-24
31. 31 Shweiki D, Ahuva I, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in homonally regulated angiogenesis. J Clin Invest 1993; 91: 2235-43
32. 32 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature 1992; 359: 843-5
33. 33 Strugar J, Criscuolo GR, Rothbart D, Harrington WN. Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic oedema and tumour-associated cysts. J Neurosurg 1995; 83: 682-9
34. 34 Strugar J, Rothbart D, Harrington W, Criscuolo GR. Vascular permeability factor in brain metastases: correlation with vasogenic brain oedema and tumour angiogenesis. J Neurosurg 1994: 81: 560-6
35. 35 Terman BC, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase receptor as a receptor for vascular endothelial growth factor. Biochem Biophys Res Comm 1992; 187: 1579-86
36. 36 Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266: 11947-54
37. 37 Weindel K, Moringlane JR, Marine D, Weich HA. Detection and quantification of vascular endothelial growth factor/ vascular permeability factor in brain tumour tissue and cyst fluid. Neurosurgery 1994; 35: 439-48
38. 38 Westphal HM, Moldenhauer G, Beato M. Monoclonal antibodies to the rat liver glucocorticoid receptor. EMBO J 1982; 1: 1467-71
39. 39 Yamada K, Ushio Y, Hayakawa T. Effects of steroids on the blood -brain barrier. In: Implications of the Blood-Brain Barrier and its Manipulation Neuwelt EA, Editor New York: Plenum, 1988; 53-76